172 results on '"Salituro Francesco G"'
Search Results
2. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Catalog
Books, media, physical & digital resources
3. Breakthroughs in neuroactive steroid drug discovery
4. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
5. Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models
6. Data from AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
7. Supplementary Tables 1 - 8 from AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
8. Supplementary Methods from AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
9. Supplementary Figures 1 - 11 from AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
10. SAGE-718: A First-in-Class N-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment
11. Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
12. Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy
13. Natural and Synthetic Neuroactive Steroid Modulators of GABAA and NMDA Receptors
14. Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities
15. Neuroactive Steroid N-Methyl-d-aspartate Receptor Positive Allosteric Modulators: Synthesis, SAR, and Pharmacological Activity
16. Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
17. AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
18. Chapter Three - Natural and Synthetic Neuroactive Steroid Modulators of GABAA and NMDA Receptors
19. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist
20. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo
21. ChemInform Abstract: 3-(2-Carboxyindol-3-yl)propionic Acid Derivatives: Antagonists of the Strychnine-Insensitive Glycine Receptor Associated with the N-Methyl-D-aspartate Receptor Complex
22. Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
23. ChemInform Abstract: Enzyme-Activated Antagonists of the Strychnine-Insensitive Glycine/ NMDA Receptor
24. Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr -/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator
25. Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)AReceptor: Structure–Activity Relationships of Heterocyclic Substitution at C-21
26. VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
27. Design, synthesis and molecular modeling of 3-acylamino-2- Carboxyindole NMDA receptor glycine-site antagonists
28. Design and Discovery of Aspartyl Protease Inhibitors
29. Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor
30. Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric...
31. Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
32. Multisubstrate Inhibition of 4-Hydroxybenzoate 3-Monooxygenase
33. Enzyme-Activated Antagonists of the Strychnine-Insensitive Glycine/NMDA Receptor
34. 2-Aminopyrazolo[1,5- a]pyrimidines as potent and selective inhibitors of JAK2
35. 3-(2-Carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex
36. Dual p38/JNK Mitogen Activated Protein Kinase Inhibitors Prevent Ozone-Induced Airway Hyperreactivity in Guinea Pigs
37. Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)
38. Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator.
39. Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain
40. Erratum: Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
41. Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
42. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles
43. The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor
44. ChemInform Abstract: Design and Synthesis of Novel Conformationally Restricted HIV Protease Inhibitors.
45. ChemInform Abstract: Design, Synthesis, and Conformational Analysis of a Novel Series of HIV Protease Inhibitors.
46. ChemInform Abstract: Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases
47. Corrigendum to “A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors” [Bioorg. Med. Chem. Lett. 20 (2010) 153]
48. Janus Kinase 2 Inhibitors. Synthesis and Characterization of a Novel Polycyclic Azaindole
49. 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site
50. Neuroactive Steroids. 1. Positive Allosteric Modulators of the (?-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.